Comparator: ezetimibe
Sponsors
Organon and Co
Conditions
HypercholesterolemiaHypercholesterolemia, FamilialLipid Metabolism, Inborn Errors
Phase 3
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
TerminatedNCT00092833
Start: 2002-07-31End: 2005-05-31Updated: 2024-08-15
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
CompletedNCT00276458
Start: 2006-02-28End: 2008-01-31Updated: 2024-05-13